Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …

Accumulating evidence indicates that long non-coding RNAs (lncRNAs) play important roles
in tumorigenesis and progression. We aimed to identify a panel of lncRNAs for the diagnosis …

Bladder cancer (BCa) is one of the 10 most common cancers with high morbidity and
mortality worldwide. Long noncoding RNAs (lncRNAs), a large class of noncoding RNA …

Cell‐free long non‐coding RNAs (lncRNAs) are stably present in urine and can serve as
non‐invasive biomarkers for cancer. We aimed to identify signatures of lncRNAs in urine for …

Several reports over the last 10 years provided evidence that long noncoding RNAs
(lncRNAs) are often altered in bladder cancers. lncRNAs are longer than 200 nucleotides …

Backgroud: Bladder cancer (BLCA) is one of the most fatal types of cancer worldwide.
However, there are limited methods for us to provide a prognostic prediction of BLCA …

Long noncoding RNAs (lncRNAs) have been implicated playing important roles in human
urologic cancers. In the present study, microarray analysis was initially performed to screen …

Dysregulation of long noncoding RNAs (lncRNAs) has been regarded as a primary feature
of several human cancers. However, the genome‑wide expression and functional …

Human bladder cancer (BCa) is one of the most commonly diagnosed malignancies
worldwide. It has high recurrence rates and low-grade malignancy, thus representing an …

The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …